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Bioassay-guided fractionation of the chloroform extract of Byrsonima fagifolia leaves led to the isolation of active antitubercular
compounds alkane dotriacontane (Minimal Inhibitory Concentration—MIC, 62.5μgmL −1), triterpenoids as bassic acid (MIC
= 2.5μgmL −1), α-amyrin acetate (MIC = 62.5μgmL −1), a mixture of lupeol, α-a n dβ-amyrin (MIC = 31.5μgmL −1)a n da
mixture of lupeol, and acetates of α-a n dβ-amyrin (MIC = 31.5μgmL −1). The antimycobacterial activity was determined by the
Microplate Alamar Blue Assay (MABA) and the structures of promising compounds were determined by spectroscopic analysis.
This investigation constitutes the ﬁrst report of a chemical and antitubercular study of apolar compounds from B. fagifolia
Niedenzu (IK).
1.Introduction
Mycobacterium tuberculosis, the agent of tuberculosis, is
responsible for high mortality worldwide, killing roughly 1.7
million people annually [1]. The situation with multidrug
resistant (MDR) tuberculosis (TB) today worries the health
authorities of the whole world, mainly in the developing
countries,wherethesituationismoresevere.Theappearance
of resistant strains to the medicines now in use makes
urgentthesearch fornewsyntheticornatural tuberculostatic
drugs. There are several reasons that justify the need to
search for new drugs for TB, for example, improvement of
current treatment by shortening its duration, to get eﬃci-
ent treatment for MDR TB and to eradicate the latent
infection. So, the development of new drugs for shortening
the duration of the treatment and to ﬁght against multidrug
resistant tuberculosis strains is urgent [2].
An approach to the search for new drugs is to look in
nature, mainly for the extremely rich and varied ﬂora of the
tropical areas. In this search, information obtained from folk
knowledge and traditional medicine of diﬀerent cultures can
be valuable. This trend in associating popular or alternative
medicine with pharmaceutical research has been growing for
some years [3].
Byrsonima fagifolia Niedenzu (IK) is a member of the
Malpighiaceae family and is a native species from the
BrazilianCerrado(savannah-like vegetation).TheCerradois
considered the most extensive woodland-savannah in South
America and contains over 5000 species of higher plants [4],
some of then with antimicrobial activities [5]. B. fagifolia is
popularly known as murici-cascudo ormurici-vermelho [6].
In Brazilian folk medicine, the leaves of B. fagifolia are used
as an antiemetic, diuretic, febrifuge and to treat peptic ulcers
[6].Previously, we also have reported theantiulceractivity of
B. crassa extracts [7] and the antidiarrhoeal activity observed
with the methanol extract of B. cinera [8]. Despite the popu-
laruseofB.fagifolia asamedicinalplant,therearenodataon
theantitubercularactivity ofitsleavesextract orcompounds.
Plants extracts are attractive sources of new drugs, and
bioassay-guided fractionation is the state-of-art process to
identify the active compounds contained in crude natural
products. The aim of this study is to evaluate by Microplate2 Evidence-Based Complementary and Alternative Medicine
Alamar Blue Assay (MABA), the potential antitubercular
activity of B. fagifolia leaves extracts, enriched fractions and
pure compounds, identiﬁed by phytochemical analysis.
2.Methods
2.1. Plant Material. The fresh leaves of B. fagifolia Niedenzu
(IK) were collected at Estrada do Brejinho de Nazar´ e,
Tocantins State, Brazil (11 ◦01 S, 48◦34 W, elevation 240m)
and the species was identiﬁed by Dr Eduardo Ribeiro dos
Santos of Tocantins University. A voucher specimen was
deposited in the herbarium of the same university under the
number 6398.
2.2. Extraction and Isolation. The air-dried and powdered
leaves (2.0kg) of B. fagifolia were extracted exhaustively with
chloroform, methanol and 80% methanol (methanol/water
80/20v/v), successively at room temperature (48h for each
solvent). Solvents were evaporated at 60◦C under reduced
pressure to yield the chloroform (92.7g), methanol (303.8g)
and 80% methanol (201.2g) extracts. The yields (w/w) for
the extracts from the dried powdersof B. fagifolia leaveswere
4.63, 15.19 and 10.06%, respectively.
A portion of the chloroform extract (10.0g) was chro-
matographed on a Merck silica gel column (15cm × 6.0i.d)
in order to separate the compounds according to their
polarity.
The column was eluated sequentially with hexane, then
dichloromethane and ﬁnally methanol. Evaporation of the
solvents yielded the dry eluatesfrom hexane (0.76g), dichlo-
romethane (3.9g) and methanol (2.2g).
The fraction eluated by hexane (0.76g) was rechromato-
graphied on a silica gel 60 column (13.0 × 2.0cmi.d.) and
eluated with pure n-hexane. Analogously, the other two frac-
tions (eluated with methanol and dichloromethane) were
fractionated on a similar column (13.0 × 3.0cmi.d.) using
pure chloroform as mobile phase, and gradually in-creasing
the polarity with methanol (for the ﬁrst fraction) or dichlo-
romethane (for the second one).
2.3. Gas Chromatography Analysis. Gas chromatography
(GC) analysis for hydrocarbon identiﬁcation was performed
using a Varian 3380 gas chromatograph equipped with a
fused silica CBP-5 capillary column (25m × 0.33mmi.d.;
ﬁlm thickness 0.5m) and a ﬂame ionization detector (FID).
Hydrogen was used as the carrier gas (60kPa), and the
injection split ratio was 1:30. The injection temperature
was 250◦C; the column temperature was held at 50◦Cf o r
1min, and then increased to 300◦Ca t1 0 ◦Cm i n −1,a n dt h i s
temperature was held for 10min; the detector temperature
was 280◦C. Samples of 1μlLwere injected using a 10μL
Hamilton syringe. The fraction eluated by hexane from the
silica gel column of the B. fagifolia extract in chloroform
w a st h e na n a l y z e db yG C ,a n dt h ec h r o m a t o g r a m sc o m p a r e d
with standard hydrocarbons (straight chain alkanes kit,C9 to
C32, from Aldrich), obtaining the retention times.
2.4. Structural Identiﬁcation of the Triterpenes. Structural
identiﬁcation of the triterpenes was performed by 13CN u -
clear Magnetic Resonance (NMR) spectroscopy. The NMR
spectra in deuterated chloroform (CDCl3)w e r eo b t a i n e d
using a Varian INOVA 500 spectrometer, operating at
500MHz for 1H and 150MHz for 13C. Chemical shifts were
given in δ (p.p.m.) using tetramethylsilane (TMS) as the
internal standard. The NMR spectra data obtained were
compared with those reported in the literature [9]. The
identiﬁcation of the isomeric amyrins and its acetates (α
and β) is perfectly possible by the 13CN M Rs p e c t r u m ,e v e n
if they are mixed, once some similar bands of the isomeric
ones have very diﬀerent chemical shifts. Similarly, other
triterpenes may be identiﬁed in mixtures, without previous
separation [10].
2.5.AntitubercularActivityAssay. Theantitubercularactivity
of chloroform, methanol and 80% methanol extracts of B.
fagifolia leaves, the enriched fractions and pure compounds
were determined using the MABA [11] as the analytical
method. Stock solutions of the tested compounds were
prepared in dimethyl sulfoxide [11]a n dw e r ed i l u t e di n
Middlebrook 7H9 (Difco) broth supplemented with oleic
acid, albumin, dextrose and catalase (OADC enrichment—
BBL/Becton-Dikinson, Sparks, MD, USA) to obtain ﬁnal
sample concentrations ranges of 0.15–1600μgmL −1.I s o -
niazid was solubilized with distilled water according to
the manufacturers’ recommendations (Difco laboratories,
Detroit, MI, USA) and used as a positive control drug. M.
tuberculosis H37Rv ATCC 27294 was grown for 7–10 days
in Middlebrook 7H9 supplemented with OADC added of
0.05%Tween 80to avoidclumps.Suspensions were prepared
and theirturbiditiesmatched to a McFarland no.1 (turbidity
standard). After further dilution of 1:25 in Middlebrook
7H9 supplemented with OADC, the inoculum was added
to each well of the 96 well microtiter plate (Falcon 3072;
Becton–Dickinson, Lincoln Park, NJ, USA) together with
the compounds. Samples were set up in triplicate. Cultures
were in incubated for 7 days at 37◦C, and after additioned
Alamar Blue for the reading. The minimum inhibitory
concentration(MIC)wasdeﬁnedasthelowestconcentration
resulting in 90% inhibition of growth of M. tuberculosis [11]
measuring the ﬂuorescence (excitation/emission of 530/590
ﬁlters, resp.) in a SPECTRAﬂuor Plus (Tecan) [12]. For
standard test, the MIC value of isoniazid was determined
each time. The acceptable MIC of Isoniazid ranged from
0.015 to 0.05μgmL −1.
3.Results
The fractions originating from the initial chromatography of
theextractinchloroformofB.fagifolia leavesweresubmitted
for subsequent column chromatographic separations, as
described in Experimental section, yielded the following
compounds:
The fraction eluated with hexane (0.76g) yielded 530mg
of the n-alkane dotriacontane and 15.4mg of the triter-
pene α-amyrin acetate. The triterpene bassic acid (234mg)
was obtained from 2.0g of the methanol eluate and the
dichloromethane fraction (2.0g) resulted in a mixture of
the triterpenes lupeol, α-a n dβ-amyrin (223mg), as well asEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: Compounds identiﬁed from the chloroform extract of Byrsonima fagifolia.
the corresponding acetates (124mg). The structures of the
compounds are shown in Figure 1. The alkane dotriacontane
was identiﬁed by GC and all triterpenes were identiﬁed by
their 13CN M Rs p e c t r a .
The chloroform, methanol and 80% methanol extracts
of leaves yielded MIC values of 62.5, 250 and 500μgmL −1,
respectively (Table 1).MIC of31.25μgmL −1 was observedin
both mixtures obtained from the dichloromethane fraction
of the chloroform extract (one with lupeol, α-a n dβ-amyrin
and the other with lupeol and acetates of α-a n dβ-amyrin).
The pure compounds α-amyrin acetate and dotriacontane,
both showed MIC of 62.5μgmL −1, and the bassic acid
presented a very promising MIC value of 2.5μgmL −1.T h e
MIC of Isoniazid, used as a positive control drug, was
0.03μgmL −1.
4.Discussion
According to Copp [13], terpenes dominate the number of
natural products reported with antimycobacterial activity.
Severalterpenes (diterpenes, sesquiterpenes, sesterpenes and
triterpenes) have demonstrated this biological activity [14].
Tosun et al. [15] considered inactive those plants extracts
that could not prevent growth of M. tuberculosis up to a
concentration of 200μgmL −1 and according to Gu et al.
[16]t h eM I Cv a l u eo f≤128μgmL −1 is deﬁned as active. In
Table 1: Determination of MIC values of extracts, fractions and
compounds from leaves of B. fagifolia against M. tuberculosis ATCC
27294, using MABA.
Samples MIC (μg/mL)
Extracts
80% MeOH 500
MeOH 250
CHCl3 62.5
Enriched fraction/compounds
Mixture of lupeol, α-a n dβ-amyrin 31.25
Mixture of lupeol, acetates of α-a n dβ-amyrin 31.25
α-Amyrin acetate 62.5
Dotriacontane 62.5
Bassic acid 2.5
Reference drug
Isoniazid 0.03
MeOH, Methanol extract; CHCl3, Chloroform extract.
the present study, the mixture of lupeol, α-a n dβ-amyrin
displayed lower MIC (31.25μgmL −1) than those previously
reported with pure lupeol [17]a n dα-a n dβ-amyrin [18]
isolated from Chuquiraga ulcina H.et A.and from Asteraceae
Martinov ﬂowers (64μgmL −1). Their synergistic activity
in the mixture might explain these results. In theory,4 Evidence-Based Complementary and Alternative Medicine
fractionation allows for the isolation of pure compounds
with higher activity than the mixture, but it is common
the original extract or the mixture to have better activity.
Houghton et al. [19]publishedan excellentreview aboutthis
matter. The mixture containing lupeol and α-a n dβ-amyrin
acetates showed the same MIC value of 31.25μgmL −1,
suggesting that the acetylation of α-a n dβ-amyrin does
not inﬂuence their activity. A MIC of 62.5μgmL −1,f o rt h e
pure acetate of α-amyrin, double the value for the mixture,
reinforces the synergistic eﬀect among the components of
the mixture against M. tuberculosis.
Inpreviousstudyperformed inBrazil,thenewtriterpene
lupenone was isolated from B. microphyla A. Juss. [20]a n
other species of Byrsonima. Lupenone was not found in B.
fagifolia but its activity against M. tuberculosis was tested by
our group being found MIC of 125 μgm L −1 (Nasser ALM
et al., unpublished data).
The triterpene bassic acid showed strong antitubercular
activity with MIC values of 2.5μgmL −1.T h i sv a l u ei s
comparable with that found by Woldemichael et al. [21]
f o rd i t e r p e n e si s o l a t e df r o mCalceolaria pinnifolia Cav. and
sterols from Ruprechitia triﬂora Griseb. with MICs of 2–
4μgmL −1. Although this MIC value is larger than the ref-
erence drug Isoniazid (MIC = 0.03μgmL −1), the inhibitory
concentration value of 2.5μgmL −1 is comparable to MICs
of the other ﬁrst-line tuberculosis drugs, such as ethambutol
(1–5μgmL −1)a n ds t r e p t o m y c i n( 2 – 8 μgmL −1), and better
than pyrazinamide (20–100μgmL −1)[ 22].
The biological activity against Leishmania [23]a n dt h e
hypoglycemic activity [24] were already described for bassic
acid but never for M. tuberculosis.
Dotriacontane is an alkane with 32 carbons, and its anti-
tubercular activity (62.5μgmL −1) was also never described
before, but the antimycobacterial activity of other alkanes
is documented in an extensive review covering 12 years
of natural products literature [16]. Two alkenes derived
from the microbial products, cerulenin and thiolactomycin,
inhibit the function of β-ketoacyl-acyl carrier protein (ACP)
synthases, which are key regulators of type II fatty acid
biosynthesis [25]. As mycolic acids are prevalent in the outer
lipid layer of mycobacteria, inhibitors of fatty acid biosyn-
thesis represent existing and potential antimycobacterial
agents.
In conclusion, the bioassay-directed fractionation of the
chloroform extract of B. fagifolia leaves yielded the pure
triterpene bassic acidwith potentanti-TB activity. Promising
activities were also veriﬁed for the mixture of lupeol, α-
amyrin and β-amyrin or their acetates, and for dotria-
contane.
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